Correlation Between Serina Therapeutics and Arrowhead Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Serina Therapeutics and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Serina Therapeutics and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Serina Therapeutics and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on Serina Therapeutics and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Serina Therapeutics with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Serina Therapeutics and Arrowhead Pharmaceuticals.

Diversification Opportunities for Serina Therapeutics and Arrowhead Pharmaceuticals

0.24

Correlation Coefficient

Serina Therapeutics  Arrowhead Pharmaceuticals

Modest diversification

The 3 months correlation between Serina and Arrowhead is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Serina Therapeutics and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and Serina Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Serina Therapeutics are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of Serina Therapeutics i.e., Serina Therapeutics and Arrowhead Pharmaceuticals go up and down completely randomly.

Pair Corralation between Serina Therapeutics and Arrowhead Pharmaceuticals

Considering the 90-day investment horizon Serina Therapeutics is expected to generate 0.99 times more return on investment than Arrowhead Pharmaceuticals. However, Serina Therapeutics is 1.01 times less risky than Arrowhead Pharmaceuticals. It trades about -0.07 of its potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about -0.1 per unit of risk. If you would invest  540.00  in Serina Therapeutics on December 21, 2024 and sell it today you would lose (86.00) from holding Serina Therapeutics or give up 15.93% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.33%
Values	Daily Returns

Serina Therapeutics  vs.  Arrowhead Pharmaceuticals

Serina Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Serina Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Arrowhead Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Arrowhead Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Serina Therapeutics and Arrowhead Pharmaceuticals

The main advantage of trading using opposite Serina Therapeutics and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Serina Therapeutics position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.

The idea behind Serina Therapeutics and Arrowhead Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.